Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer

Terry Z. Liu; Ling Wang; Shugeng Gao; Qi Xue; Fengwei Tan; Yushun Gao

doi:10.1186/s13019-025-03719-w

Affiliated Institutions

Related Publications

The National Lung Screening Trial: Overview and Study Design

Constantine A. Gatsonis , Denise R. Aberle , Christine D. Berg +97 more

The National Lung Screening Trial (NLST) is a randomized multicenter study comparing low-dose helical computed tomography (CT) with chest radiography in the screening of older c...

2010 Radiology 1227 citations

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma , Rafael Santana-Dávila , Julian R. Molina

Lung cancer remains the leading cause of cancer deaths in the United States. In the past decade, significant advances have been made in the science of non-small cell lung cancer...

2019 Mayo Clinic Proceedings 2089 citations

ACR CT Accreditation Program and the Lung Cancer Screening Program Designation

Ella A. Kazerooni , Mark Armstrong , Dina Hernandez +5 more

The ACR recognizes that low-dose CT for lung cancer screening has the potential to significantly reduce mortality from lung cancer in the appropriate high-risk population. The A...

2014 Journal of the American College of Ra... 80 citations

Risk‐based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch‐Belgian randomised lung cancer multi‐slice CT screening trial (NELSON)

Carola A. van Iersel , Harry J. de Koning , Gerrit Draisma +7 more

Abstract A method to obtain the optimal selection criteria, taking into account available resources and capacity and the impact on power, is presented for the Dutch‐Belgian rand...

2006 International Journal of Cancer 484 citations

Screening for Lung Cancer

Alex H. Krist , Karina W. Davidson , Carol M. Mangione +16 more

The USPSTF recommends annual screening for lung cancer with LDCT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within th...

2021 JAMA 1504 citations

Publication Info

Year: 2025
Type: article
Volume: 20
Issue: 1
Pages: 456-456
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Terry Z. Liu, 
                                
                                    Ling Wang, 
                                
                                    Shugeng Gao
                                
                                et al.
                            
                            (2025). 
                            Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer. 
                            Journal of Cardiothoracic Surgery
                            , 20
                            (1)
                            , 456-456.
                            https://doi.org/10.1186/s13019-025-03719-w
                        

Identifiers

DOI: 10.1186/s13019-025-03719-w